US2020347019A1PendingUtilityA1

Quinoline-based proteasome inhibitors and uses thereof

Assignee: UNIV MICHIGAN STATEPriority: Mar 31, 2017Filed: Jul 20, 2020Published: Nov 5, 2020
Est. expiryMar 31, 2037(~10.7 yrs left)· nominal 20-yr term from priority
A61P 35/00A61K 31/47C07D 215/06
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A compound of the formula II: 
       
         
           
           
               
               
           
         
         wherein: 
         R 6  is hydrogen, alkyl or aryl; 
         R 7  is hydrogen, alkyl, alkenyl, cycloalkyl, aryl, cycloheteroalkyl or alkoxy; 
         R 8  is hydrogen, halogen, or alkyl; 
         R 9  is hydrogen, halogen, hydroxy, alkyl, alkoxy, aminoalkyl or heterocyclyl; and 
         R 10  is hydrogen, halogen, lower alkyl, or lower alkoxy.

Join the waitlist — get patent alerts

Track US2020347019A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.